Optimist Retirement Group’s Corcept Therapeutics CORT Stock Holding History

Optimist Retirement Group’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$445K	Buy	+3,858	New	+$415K	0.18%	80

Other funds holding CORT

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Ingalls & Snyder LLC New York $3.91B AUM 60.54% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Optimist Retirement Group's CORT Position: Q3 2026 in Review

Optimist Retirement Group opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 3,858 shares worth $445K. The stake represents 0.18% of the portfolio and ranks #80 among its holdings.

403 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

Optimist Retirement Group held 3,858 shares of Corcept Therapeutics worth $445K as of Q3 2026.
Corcept Therapeutics was a new Optimist Retirement Group position in Q3 2026.
Corcept Therapeutics made up 0.18% of Optimist Retirement Group's portfolio in Q3 2026, its #80 holding.
403 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Optimist Retirement Group's 13F filing for Q3 2026, filed 30 Oct 2026.